We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Akili Inc is a digital medicine company pioneering the development of cognitive treatments through game-changing technologies. Akili Inc is a digital medicine company pioneering the development of cognitive treatments through game-changing technologies.
FY 2023 total revenues of $1.7M, a 420% increase over FY 2022 as EndeavorOTCⓇ gained traction in the market following June 2023 product release Reports fourth quarter 2023 total revenues of $749...
Japanese Product Now Under Review for Nationwide Marketing Approval PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated...
Japanese Product Now Under Review for Nationwide Marketing Approval Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that its Japanese partner Shionogi & Co...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0075 | 3.15789473684 | 0.2375 | 0.26 | 0.221 | 73443 | 0.24075658 | CS |
4 | -0.045 | -15.5172413793 | 0.29 | 0.299999 | 0.21 | 93449 | 0.24589694 | CS |
12 | 0.0022 | 0.906095551895 | 0.2428 | 0.7384 | 0.1912 | 2582257 | 0.43947491 | CS |
26 | -0.2505 | -50.5549949546 | 0.4955 | 0.7384 | 0.1912 | 1267243 | 0.43833878 | CS |
52 | -0.815 | -76.8867924528 | 1.06 | 1.67 | 0.1912 | 752576 | 0.59684219 | CS |
156 | -36.515 | -99.3335146899 | 36.76 | 37.5807 | 0.1912 | 602263 | 1.48992758 | CS |
260 | -36.515 | -99.3335146899 | 36.76 | 37.5807 | 0.1912 | 602263 | 1.48992758 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions